Earnings

Filana Therapeutics Q3 EPS $(0.22) Beats $(0.24) Estimate

Nov 5, 2026 · 08:26 AM ET· updated 1h ago

Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is unchanged from the same period last year.

Why It Matters

Filana lost less money per share than experts predicted. When a company loses money slower than expected, it shows better control of spending.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

FLNA0.57

-0.00 (-0.58%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.